Current strategies on pathogen removal/inactivation: An overview

Transfusion and Apheresis Science

Volumn 25, Issue 3, 2001, Pages 195-197

  Allain, Jean Pierre ^a   Seghatchian, Jerard ^b,c  

^a East Anglia Blood Centre   (United Kingdom)

^b NHS BLOOD AND TRANSPLANT   (United Kingdom)

^c NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOTOSALEN; DISINFECTANT AGENT; METHYLENE BLUE; NUCLEIC ACID; PSORALEN; RIBOFLAVIN; S 303; THIONINE; THROMBOCYTE CONCENTRATE; UNCLASSIFIED DRUG;

ALLOIMMUNIZATION; BLOOD CLOTTING FACTOR DEFICIENCY; CARCINOGENICITY; CELL SURVIVAL; CLINICAL TRIAL; DEVICE; ERYTHROCYTE CONCENTRATE; GENOTOXICITY; HEMOSTASIS; HUMAN; ILLUMINATION; MUTAGENICITY; NONHUMAN; PLASMA; SHORT SURVEY; THROMBOCYTE; THROMBOCYTE PRESERVATION; THROMBOCYTE TRANSFUSION; THROMBOTIC THROMBOCYTOPENIC PURPURA; ULTRAVIOLET RADIATION; VIRUS ENVELOPE; VIRUS INACTIVATION;

EID: 0035209411     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-0502(01)00122-7     Document Type: Article

References (0)